Research and strategy recommendations on the pharmaceutical sector and health sector in West and East Africa
By Webmaster
Published On September 23, 2020
Research and strategy recommendations on the pharmaceutical sector and health sector in West and East Africa
In January 2020, AHB was contracted to perform three market studies within the healthcare sector in Africa, concerning the pharmaceutical sector and the health sector in general
- Review alternatives for safe pharmaceutical production and distribution in West and East Africa by using concrete business examples from the company’s pipeline.
- Perform a gap analysis of the private healthcare sector in East Africa by using one of the company’s portfolio companies as an example.
- Analyze which types of companies are best equipped to address the largest gaps within the health sector in West and East Africa.
Approach and methodology
AHB conducted this assignment in three different phases; the inception phase, the implementation phase and the reporting phase.
Inception
The goal of the inception phase is to understand the project requirements in detail and ensure that the work plan aligns with the vision for this project and beyond through a one-day introductory meeting.
Implementation
The implementation phase included desk study, market research and phone interviews and site visits for in-depth interviews and focus group discussions with relevant staff at the pharmaceutical companies as well as the private healthcare provider.
Reporting
During the reporting phase, a draft report and final report were presented including strategic recommendations and examples of good practice.
AHB conducted this assignment in three different phases; the inception phase, the implementation phase and the reporting phase.
Inception
The goal of the inception phase is to understand the project requirements in detail and ensure that the work plan aligns with the vision for this project and beyond through a one-day introductory meeting.
Implementation
The implementation phase included desk study, market research and phone interviews and site visits for in-depth interviews and focus group discussions with relevant staff at the pharmaceutical companies as well as the private healthcare provider.
Reporting
During the reporting phase, a draft report and final report were presented including strategic recommendations and examples of good practice.
Outcomes
As a result, the organization was presented with insights to make an informed decision on appropriate investments and strategies for East and West Africa.
Assignment 1
a. Description of the pharmaceutical market in the targeted regions (East and West Africa).
b. A full review of the pipeline companies within the pharmaceutical sector and the pharmaceutical market in the targeted regions.
c. The pros and cons in their choice of business model (manufacturing vs. distribution).
d. A conclusion including which model seems most efficient in terms of impact results.
e. Suggested alternatives, should this seem relevant.
Assignment 2
a. Description of the healthcare market in the West and East African region.
b. Description of the private healthcare provider, how the provider operates and its business model.
c. Description of public healthcare in the area.
d. Description of the impact effect on healthcare access stemming from the private healthcare provider operating in the area.
Assignment 3
a. Description of the gaps that exist in the West and East African healthcare market for achieving SDG 3.
b. Overview of healthcare companies currently operating in the market addressing access to health for middle and low-income populations in East and West Africa.
c. Recommendations of the types of companies in East and West Africa that best address the gaps.